Aarti Pharmalabs Ltd.

The revenue for the June 2024 quarter is pegged at Rs. 3934.86 millions, about 9.87% up against Rs. 3581.44 millions recorded during the year-ago period.Net profit declined -1.02% to Rs. 471.44 millions from Rs. 476.32 millions.Operating profit for the quarter ended June 2024 rose to 857.68 millions as compared to 816.03 millions of corresponding quarter ended June 2023.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202406	202306	% Var	202406	202306	% Var	202403	202303	% Var
Sales	3934.86	3581.44	9.87	3934.86	3581.44	9.87	15021.30	15112.50	-0.60
Other Income	21.13	48.59	-56.51	21.13	48.59	-56.51	110.10	12.80	760.16
PBIDT	857.68	816.03	5.10	857.68	816.03	5.10	3571.60	3096.20	15.35
Interest	42.49	40.34	5.33	42.49	40.34	5.33	166.30	204.90	-18.84
PBDT	815.19	775.69	5.09	815.19	775.69	5.09	3405.30	2891.30	17.78
Depreciation	182.93	154.37	18.50	182.93	154.37	18.50	660.10	557.70	18.36
PBT	632.26	621.32	1.76	632.26	621.32	1.76	2745.20	2333.60	17.64
TAX	160.82	145.00	10.91	160.82	145.00	10.91	738.70	616.30	19.86
Deferred Tax	45.15	35.00	29.00	45.15	35.00	29.00	278.10	95.00	192.74
PAT	471.44	476.32	-1.02	471.44	476.32	-1.02	2006.50	1717.30	16.84
Equity	453.13	453.13	0.00	453.13	453.13	0.00	453.10	453.10	0.00
PBIDTM(%)	21.80	22.78	-4.34	21.80	22.78	-4.34	23.78	20.49	16.05